Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0120
+0.0005 (4.35%)
Aug 11, 2026, 10:20 AM EST
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $807.17 thousand as of August 11, 2026. Its market cap has decreased by -2.78% in one year.
Market Cap
807.17K
Enterprise Value
31.69M
Revenue
12.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 807.17K, a decrease of -99.77%. That is a compound annual growth rate of -57.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 807.17K | -2.78% |
| Dec 31, 2025 | 830.25K | 52.94% |
| Dec 31, 2024 | 542.86K | -91.23% |
| Dec 29, 2023 | 6.19M | -52.02% |
| Dec 30, 2022 | 12.90M | -84.34% |
| Dec 31, 2021 | 82.35M | 36.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ZyVersa Therapeutics | 955.32K |
| AXIM Biotechnologies | 944.13K |
| CERo Therapeutics Holdings | 928.41K |
| Regenerative Medical Technology Group | 919.73K |
| Avenue Therapeutics | 840.55K |
| Agentix | 801.34K |
| Nextel Medical | 790.37K |
| SQZ Biotechnologies Company | 707.79K |